Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | F7 | P08709 | 5/20 | 1.00 |
| ▸ | F3 | P13726 | 5/20 | 1.00 |
| ▸ | FABP4 | P15090 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | DUSP3 | P51452 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16685715 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL15880317 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Linoleic Acid SCHEMBL20856202 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498259 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498256 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Arachidic Acid SCHEMBL20528087 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Linoleic Acid SCHEMBL25294178 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL22498258 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| Dihomo-Gamma-Linolenic Acid SCHEMBL20656585 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 | |
| SCHEMBL21411004 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024108603-A1 | FECAL METABOLITE-BASED NEURODEGENERATIVE DISEASE MARKER, AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2024-05-30 | — | — | WO | claimed |
| CN-118090931-A | Neurodegenerative disease marker based on fecal metabolites and application thereof | 中国科学院深圳先进技术研究院 | 2024-05-28 | — | — | CN | claimed |
| US-20100069491-A1 | LIPID-AMINO ACID CONJUGATES AND METHODS OF USE | UNIVERSITY OF MASSACHUSETTS (US) | 2010-03-18 | — | — | US | claimed |
| US-7544714-B2 | Lipid-amino acid conjugates and methods of use | UNIVERSITY OF MASSACHUSETTS (US) | 2009-06-09 | — | — | US | claimed |
| EP-1778210-A2 | LIPID-AMINO ACID CONJUGATES AND METHODS OF USE | University of Massachusetts (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006010153-A2 | LIPID-AMINO ACID CONJUGATES AND METHODS OF USE | UNIVERSITY OF MASSACHUSETTS (US) | 2006-01-26 | — | — | WO | claimed |
| US-20060014820-A1 | Lipid-amino acid conjugates and methods of use | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-01-19 | — | — | US | claimed |
| US-20260146254-A1 | Enhancing Oligonucleotide Immunomodulatory Activity through Dianophore Long-Lasting Modification: Methods and Applications | SEGENA CORPORATION S.A. (UY) | 2026-05-28 | — | — | US | disclosed |
| EP-4622674-A1 | ENHANCING OLIGONUCLEOTIDE IMMUNOMODULATORY ACTIVITY THROUGH DIANOPHORE LONG-LASTING MODIFICATION: METHODS AND APPLICATIONS | SEGENA CORPORATION S.A. (UY) | 2025-10-01 | — | — | EP | disclosed |
| US-20250143359-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2025-05-08 | — | — | US | disclosed |
| EP-4150103-B1 | METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS | U WINDMOELLER INNOVATION GMBH & CO KG (DE) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| US-12207672-B2 | Compounds that modulate GPR92 receptor activity and pet food products containing the same | MARS, INCORPORATED (US) | 2025-01-28 | — | — | US | disclosed |
| EP-1188440-A1 | MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2002-03-20 | — | — | EP | disclosed |
| EP-0827401-A2 | METHODS AND COMPOSITIONS FOR INHIBITING ALPHA-REDUCTASE ACTIVITY | ARCH DEVELOPMENT CORPORATION (US) | 1998-03-11 | — | — | EP | disclosed |
| US-5605929-A | REDUCING WEIGHT IN ANIMALS | ARCH DEVELOPMENT CORP. (US) | 1997-02-25 | — | — | US | disclosed |
| WO-1996037201-A2 | METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY | ARCH DEVELOPMENT CORPORATION (US) | 1996-11-28 | — | — | WO | disclosed |
| EP-0132346-B1 | NOVEL COMPOUNDS AND COMPOSITIONS USEFUL FOR PRODUCING ANALGESIA | THE PROCTER & GAMBLE COMPANY (US) | 1986-09-24 | — | — | EP | disclosed |
| US-4544669-A | ALKADIENAMIDES | THE PROCTER & GAMBLE COMPANY (US) | 1985-10-01 | — | — | US | disclosed |
| EP-0132346-A1 | Novel compounds and compositions useful for producing analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014820-A1 | Lipid-amino acid conjugates and methods of use | SLC27A2, SLC27A1, FABP2 | PPARG 160/4885PPARD 447/4885PPARA 224/4885 |
| US-20100069491-A1 | LIPID-AMINO ACID CONJUGATES AND METHODS OF USE | SLC27A2, SLC27A1, FABP2 | PPARG 160/4885PPARD 447/4885PPARA 224/4885 |
| US-20260146254-A1 | Enhancing Oligonucleotide Immunomodulatory Activity through Dianophore Long-Lasting Modification: Methods and Applications | CD44, ADAR, TLR9 | PPARG 1357/4885PPARD 2310/4885PPARA 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.